TY  - JOUR
AU  - Atienza Mateo, Belén
AU  - Pato, Esperanza
AU  - Díaz Valle, David
AU  - López Longo, Francisco Javier
AU  - Blanco, Ricardo
PY  - 2019
DO  - 10.1002/ART.41026
SN  - 2326-5205
UR  - https://hdl.handle.net/20.500.14352/112850
T2  - Arthritis and Rheumatology
AB  - Objective: To compare the efficacy of infliximab (IFX) versus adalimumab (ADA) as a first-line biologic drug over 1 year of treatment in a large series of patients with refractory uveitis due to Behçet's disease (BD). Methods: We conducted an...
LA  - eng
M2  - 2081
PB  - Wiley
KW  - Uveitis
KW  - Behçet disease
KW  - Infliximab
KW  - Adalimumab
KW  - Multicenter study
TI  - Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
TY  - journal article
VL  - 71
ER  -